O-GlcNAcylation of ZEB1 facilitated mesenchymal pancreatic cancer cell ferroptosis
Open Access
- 1 January 2022
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 18 (10) , 4135-4150
Abstract
Background: Mesenchymal cancer cells, resistant to the traditional regulated cell death, are exquisitely vulnerable to ferroptosis. However, the underlying mechanism has been rarely studied. While glycolipid metabolism rewiring is a critical determination of both cancer cell mesenchymal phenotype and cell death resistance, we are interested in the underlying cross talk between glycolipid metabolism and mesenchymal cancer cell ferroptosis sensitivity.Keywords
This publication has 32 references indexed in Scilit:
- Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathwayNature, 2017
- Protein O-GlcNAcylation: emerging mechanisms and functionsNature Reviews Molecular Cell Biology, 2017
- The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesisNature Communications, 2017
- The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancerNature Cell Biology, 2017
- Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor GrowthCancer Cell, 2015
- Oncogenic roles of EMT-inducing transcription factorsNature Cell Biology, 2014
- A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer MetastasisCancer Cell, 2014
- Activation of the Transcriptional Function of the NF-κB Protein c-Rel by O -GlcNAc GlycosylationScience Signaling, 2013
- A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell SurvivalCancer Cell, 2009
- O -linkage of N -acetylglucosamine to Sp1 activation domain inhibits its transcriptional capabilityProceedings of the National Academy of Sciences, 2001